ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.917,73
0,65%
S&P 500
5.485,43
0,22%
US Dollar vs BRL
5,4114
-0,26%
Bitcoin
64.642,29
-2,77%
Brent Oil
84,375
0,57%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Poseida Therapeutics Inc (PSTX)

  7. Poseida Therapeutics Inc (PSTX) Notícias

PSTX

Poseida Therapeutics (PSTX)

Poseida Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PSTX
DataHoraFonteTítuloCódigoCompanhia
03/06/202417:05PR Newswire (US)Poseida Therapeutics Announces Virtual 2024 Annual Meeting of StockholdersNASDAQ:PSTXPoseida Therapeutics Inc
14/05/202417:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTXPoseida Therapeutics Inc
14/05/202417:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTXPoseida Therapeutics Inc
14/05/202417:05PR Newswire (US)Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024NASDAQ:PSTXPoseida Therapeutics Inc
09/05/202410:00PR Newswire (US)Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual MeetingNASDAQ:PSTXPoseida Therapeutics Inc
06/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSTXPoseida Therapeutics Inc
01/05/202422:30PR Newswire (US)Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in OncologyNASDAQ:PSTXPoseida Therapeutics Inc
01/05/202416:25AllPennyStocks.comBiotech Soars on Research Collaboration And License Agreement ReleaseNASDAQ:PSTXPoseida Therapeutics Inc
18/04/202409:00PR Newswire (US)Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:PSTXPoseida Therapeutics Inc
17/04/202410:00PR Newswire (US)Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline FocusNASDAQ:PSTXPoseida Therapeutics Inc
08/04/202413:00PR Newswire (US)Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple MyelomaNASDAQ:PSTXPoseida Therapeutics Inc
01/04/202417:05PR Newswire (US)Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSTXPoseida Therapeutics Inc
25/03/202417:05PR Newswire (US)Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical OfficerNASDAQ:PSTXPoseida Therapeutics Inc
19/03/202417:05PR Newswire (US)Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:PSTXPoseida Therapeutics Inc
13/03/202417:05PR Newswire (US)Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple MyelomaNASDAQ:PSTXPoseida Therapeutics Inc
07/03/202418:07PR Newswire (US)Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023NASDAQ:PSTXPoseida Therapeutics Inc
04/03/202419:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTXPoseida Therapeutics Inc
08/02/202418:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PSTXPoseida Therapeutics Inc
04/01/202410:00PR Newswire (US)Poseida Therapeutics Highlights Recent Progress, Strategic Priorities and Anticipated 2024 Key MilestonesNASDAQ:PSTXPoseida Therapeutics Inc
11/12/202312:31Dow Jones NewsPoseida Therapeutics Shares Climb on Positive Data for Blood Cancer TreatmentNASDAQ:PSTXPoseida Therapeutics Inc
10/12/202314:00PR Newswire (US)Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:PSTXPoseida Therapeutics Inc
09/11/202318:05PR Newswire (US)Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023NASDAQ:PSTXPoseida Therapeutics Inc
07/11/202310:00PR Newswire (US)Poseida Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:PSTXPoseida Therapeutics Inc
02/11/202310:01PR Newswire (US)Poseida Therapeutics to Present at the 65th ASH Annual Meeting and ExpositionNASDAQ:PSTXPoseida Therapeutics Inc
09/10/202317:30PR Newswire (US)Poseida Therapeutics Announces Leadership TransitionNASDAQ:PSTXPoseida Therapeutics Inc
14/08/202317:41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PSTXPoseida Therapeutics Inc
11/08/202317:48Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PSTXPoseida Therapeutics Inc
08/08/202317:05PR Newswire (US)Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023NASDAQ:PSTXPoseida Therapeutics Inc
07/08/202311:41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsNASDAQ:PSTXPoseida Therapeutics Inc
07/08/202310:58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasNASDAQ:PSTXPoseida Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PSTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HAGA3
HAGA ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
TELB4
TELEBRAS PN
BOV
CSNA3
SID NACIONAL ON
BOV
QUAL3
QUALICORP ON
BOV
AMAR3
LOJAS MARISA ON
BOV
SGPS3
SPRINGS ON
BOV
TECN3
TECHNOS ON
BOV
JHSF3
JHSF PART ON
BOV
POMO4
MARCOPOLO PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados